Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses

de Witte, Chris Jenske, Espejo Valle-Inclan, Jose, Hami, Nizar, Lõhmussaar, Kadi, Kopper, Oded, Vreuls, Celien Philomena Henrieke, Jonges, Geertruida Nellie, van Diest, Paul +8 more·2020·Cell Reports

DOI 10.1016/j.celrep.2020.107762

Cited by (307)

Items 201–300 of 307

Three-dimensional models: from cell culture to Patient-Derived Organoid and its application to future liposarcoma research
Sayumi Tahara, Sydney Rentsch, Fernanda Costas Casal de Faria, Patricia Sarchet, Roma Karna, Raphael E. Pollock, Federica Calore · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐ x L or Mcl‐1 in ovarian cancer
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Émilie Brotin, Mélanie Briand, Énora Dolivet, Laurent Poulain et al. · 2025 · Molecular Oncology
Advances in In Vitro Modeling of Cancer‐Stromal Interactions: From Fundamental Insights to Translational Applications
Zhuoran Wu, Bingyi Zeng, Dong Hua Seah, Ian Zi Rui Ng, Rockie Haiyao Ding, Tianyi Zhang, Madhumathi Kalaichelvan, Ruochii You, Eliza Li Shan Fong · 2025 · Advanced Materials
Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study
Jack Scanlan, Parul Mittal, Noor A. Lokman, Martin Klaus Oehler, Peter Hoffmann, Manuela Klingler‐Hoffmann · 2025 · Journal of Proteome Research
Culturally responsive strategies and practical considerations for live tissue studies in Māori participant cohorts
Helena Abolins-Thompson, Kimiora L. Henare, Bridget Simonson, Mark D. Chaffin, Patrick T. Ellinor, Claire Henry, Mairarangi Haimona, Jake Aitken, Taku Parai, Bianca Elkington et al. · 2024 · Frontiers in Research Metrics and Analytics
Establishing predictive machine learning models for drug responses in patient derived cell culture
Abbi Abdel‐Rehim, Oghenejokpeme I. Orhobor, Gareth Griffiths, Larisa Soldatova, Ross D. King · 2025 · npj Precision Oncology
Organoids and epithelial ovarian cancer ‑ a future tool for personalized treatment decisions?
Yagmur Sisman, Tine Henrichsen Schnack, Estrid Vilma Solyom Høgdall, Claus Kim Høgdall · 2021 · Molecular and Clinical Oncology
Les organoïdes derives de tumeurs (ou tumoroïdes), des outils de choix pour la medecine de precision en oncologie
Marion Perréard, Romane Florent, Lucie Thorel, Audrey Vincent, Louis‐Bastien Weiswald, Laurent Poulain · 2022 · médecine/sciences
AAV for ovarian cancer gene therapy
Hee Chan Yoo, Sang-Kil Lee, Joong Yull Park, Eun‐Ju Lee · 2025 · Cancer Gene Therapy
CT radiomic stratification signature to optimize clinical decisions for ovarian cancer patients receiving neoadjuvant chemotherapy and the underlying biological basis: a multicenter retrospective study
Shimin Zhang, Xinyue Li, Siyang Zhang, Meiyao Li, Jiarui Wang, Jiage Zhang, Yutong Liu, Zhuonan Liu, Guan Wang, Yi Zhang et al. · 2025 · Journal of Translational Medicine
Microfluidic single-cell culture represents a versatile approach for tumor stem cell expansion and tumor organoid generation
Jueming Chen, Wang Xiao-gang, Weijie Ye, Hui Kang, Siyan Xiao, Jiayu Li, Lihui Wang, Dongguo Lin, D. Liu · 2026 · Lab on a Chip
Fully synthetic nanofibrillar hydrogel for the growth and enzyme-free release of patient-derived ovarian tumor organoids
Yixiong Duan, Yuchuan Jin, Yiyang Jia, Mingyue Zhao, Lang Bai, Shoujun Zhu, Zhentong Wei, Songling Zhang, Bai Yang, Yunfeng Li · 2025 · Biomaterials
Integrating inverse reinforcement learning into data-driven mechanistic computational models: a novel paradigm to decode cancer cell heterogeneity
Patrick C. Kinnunen, Kenneth K. Y. Ho, Siddhartha Srivastava, Chengyang Huang, Wanggang Shen, Krishna Garikipati, Gary D. Luker, Nikola Banović, Xun Huan, Jennifer J. Linderman et al. · 2024 · Frontiers in Systems Biology
Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors
Sanju Sinha, Rahulsimham Vegesna, Saugato Rahman Dhruba, Wei Wu, Daniel Lucas Kerr, Oleg V. Stroganov, Ivan V. Grishagin, Kenneth Aldape, Collin Michael Blakely, Peng Jiang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Transcriptomic profiling of organoids derived from malignant effusions uncovers lncRNA MEG3 and target genes potentially involved in platinum resistance in serous ovarian carcinoma
Naiade Calanca, Cláudia Aparecida Rainho, Debora Kazumi Maeda, Luiza Côrtes, Rolando André Rios Villacis, Daniela Bizinelli, Hellen Kuasne, Mads Malik Aagaard, Lars Ulrik Fokdal, Karina Dahl Steffensen et al. · 2025 · Biomedicine & Pharmacotherapy
zAvatar-test—A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study
Marta F Estrada, Filipa Amorim, Filipa Ferreira da Silva, Cátia Rebelo de Almeida, Márcia Fontes, Ricardo Coelho, Sónia Ferreira, Rita Canas‐Marques, Mireia Castillo-Martín, João Casanova et al. · 2025 · Cell Reports Medicine
Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C
Kyah van Megesen, Arianna Stefan, M.M. Kieboom, Rebecca Amico, Anne M. L. Jansen, Inne H.M. Borel Rinkes, Onno Kranenburg · 2026 · British Journal of Cancer
Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids
Emily J. Tomas, Jennifer Davis, Yudith Ramos Valdés, Trevor G. Shepherd · 2026 · Cancer Biology & Therapy
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages
Kathleen M Burkhard, Ayush Semwal, Benjamin K. Johnson, Kristina C. Chu, Riley Kranick, Mihika Rayan, Analisa V. DiFeo, Hui Shen, Geeta Mehta · 2026 · Acta Biomaterialia
Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes
Shuangzhe Lin, Karthikeyan Narayanan, Deepak Vashishth · 2026 · Advanced Science
The application and research advances of organoids in clinical medicine
Shaobo Mo, Ruo‐Yu Guan, Zhang Long, Sanjun Cai, Junjie Peng, GuoQiang HUA · 2021 · Scientia Sinica Vitae
Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
Nicholas Michael, Naris Nilubol · 2022 · Cancers
Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues
Manuel Cabeza-Segura, Blanca García-Micó, Andrès M.R. Cervantes, Josefa Castillo · 2024 · Methods in molecular biology
Parallel Acceleration of Genome Variation Detection on Multi-Zone Heterogeneous System
Yaning Yang, Xiaoqi Wang, Chengqing Li, Shaoliang Peng · 2025 · IEEE Transactions on Parallel and Distributed Systems
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing drugs in RB1-deficient ovarian and breast cancer cells
Daria R. Bulanova, Yevhen A. Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas, Sanna H. Timonen, Manar Elmadani, Johanna Hynninen, Sampsa Hautaniemi, Tero A. Aittokallio et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Models of High-Grade Serous Ovarian Carcinoma
Oscar J. Pundel, Benjamin G. Neel · 2025 · Cold Spring Harbor Perspectives in Medicine
Vascularized tumor organoids enable immunotherapy testing in tumor-remodeled stroma
Reiner Wimmer, Rok Krese, Louisa Henniger, Steve Niu, Nadege Lagarde, Timon Keller, Inga Clausen, Fabian Köchel, Claudia Ferrara, Inja Waldhauer et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism
Jiejing Kai, Xueling Liu, Meijia Wu, Pan Liu, Meihua Lin, Hongyu Yang, Qingwei Zhao · 2025 · Personalized Medicine
Establishment and Characterization of a Durable and Versatile Endometrial Cancer Organoid Database
Yifen Li, Gangwei Wang, Jianwei Chen, Xingping Xu, Tao Xu, Xuefeng Jiang, Yu Zhang · 2025 · Indian Journal of Gynecologic Oncology
An organoid-guided platform for ovarian cancer: enabling prediction of patients’ chemotherapy response
Ling Wang, Misi He, Xueping Zhu, Lifang Ma, Lin Zhong, Qingxiu Jiang, Qiaoling Li, Hongji Wu, Haixia Wang, Dongling Zou · 2026 · Journal of Ovarian Research
Tumor Microenvironment of Epithelial Ovarian Cancer
Rachel S. Perkins, Won-Young Choi, Matthew S. Jung and; Wenjing Zhang · 2025 · IntechOpen eBooks
A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response
Christiane Helgestad Gjerde, Katrin Kleinmanns, Anika Langer, Gorka Ruiz de Garibay Ponce, Ezekiel R. Rozmus, Gina Nyhus Stangeland, Calum Leitch, Rammah Elnour, Harsh Dongre, Constantin Berger et al. · 2026 · EBioMedicine
Engineering immune-competent niches: strategies, applications, and translational hurdles in ovarian cancer organoid models
Yuying Chen, N. L. Jing Xu, Mingxin Dong, Wensen Liu, Ziwei Liu, Guangchao Sun, Yan Jia · 2026 · Frontiers in Immunology
An organoid-guided roadmap for precision delivery of epigallocatechin gallate in oral submucous fibrosis
Chenpeng Chen, An Gan, Chenggong Huang, Yishun Weng, Tao Wang · 2026 · Frontiers in Bioengineering and Biotechnology
Recent Applications of Tissue-Engineered 3D Scaffolds in Oncology: Present and Future Perspectives
Devika Tripathi, Vivek Kumar Gupta, Prashant Kumar Pandey · 2026 · Protein and Peptide Letters
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors
Mingxia Ye, Yawen Wu, Zexin Chen, Qingzhi Zhai, Lian Li, Zhifeng Yan, Mingxia Li, Chenglei Gu, Wen Yang, Shujie Liao et al. · 2026 · Drug Resistance Updates
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical response
Alexandra M. Gustafson, Aarushi Bhasin, Billel Gasmi, Brian D. Bui, Catherine M. Ade, Ken‐ichi Hanada, Hyunmi K. Halas, Jared J. Gartner, Todd D. Prickett, Jon Salazar et al. · 2026 · Journal for ImmunoTherapy of Cancer
Patient-Derived Organoids in Clinical Medicine: Proven Impact and Future Directions
Magdalena Skowrońska, Ece Yıldız, Jens Grosch, Mairene Coto‐Llerena · 2026 · Organoids
Nanoscale Drug Delivery Systems for Ovarian Cancer: Targeting Strategies, Theranostic Platforms, and Translational Challenges
Xinyue Hu, Yu Zhang, Yueda Lu, Fangqi Zheng, Kaiyu Zhang, Mengxing Jiang, Chen Chen, Zhaolian Wei, Jianye Wang · 2026 · Small
A pH-sensitive nanococktail enabled cancer stem cell elimination, deep tumour penetration, and tumour shrinkage
Kamel S. Ahmed, Emma Nolan, Jingjing Wang, Stephen M. F. Jamieson, Patrick Pan, Dengxuan Mao, David J.T. Porter, George Robert Laking, Nianping Feng, Andrew Neil Shelling et al. · 2026 · International Journal of Pharmaceutics
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza Numan Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela E. Guevara, John R. Otilano, Jenna E. Moyer, Marvel Tranquille et al. · 2026 · Science Advances
Cytotoxic effect of 13α-estrane derivatives on breast, endometrial and ovarian cancer cell lines
Alja Zottel, Rebeka Jójárt, Henrietta Ágoston, Eva Hafner, Neža Lipušček, Erzsébet Mernyák, Tea Lanišnik Rižner · 2023 · The Journal of Steroid Biochemistry and Molecular Biology
Tumor Ecosystem-Mimicking Bioengineering Methods
Phei Er Saw, Erwei Song · 2023 · Springer eBooks
Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Geertruid Johanna Brink, Nizar Hami, Sander Mertens, Hans W. Nijman, Luc R.C.W. van Lonkhuijzen, Eva Maria Roes, Christianne A. R. Lok, Cor Doede de Kroon, Jurgen M.J. Piek, Ward Hofhuis et al. · 2024 · Molecular Cancer Therapeutics
Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models
Akshi Srivastava, Christine Unterweger, Sarah Guttmann, Andrea Wolf, Leonhard Müllauer, Martin Schepelmann, Dan Cacsire Castillo‐Tong, Thomas Bartl · 2025 · International Journal of Molecular Sciences
NPEPPS is a novel and druggable driver of platinum resistance
Robert T. Jones, Mathijs Scholtes, Andrew E. Goodspeed, Maryam Akbarzadeh, Saswat Mohapatra, Lily Elizabeth Feldman, Hedvig Vékony, Annie Jean, Charlene B. Tilton, Michael V. Orman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
ODFormer: a Virtual Organoid for Predicting Personalized Therapeutic Responses in Pancreatic Cancer
Jing Xu, Xiaolu Yang, Yunguang Li, Huang Wang, Yikai Li, Shijie Tang, Shiwei Guo, Jiawei Zou, Xiaohan Shi, Zexi Chen et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Intratumoral Cellular Heterogeneity Critically Determines Extracellular Vesicle Uptake in Colorectal Cancer
Andrea Kelemen, Idan Carmi, Ádám Oszvald, Péter Lőrincz, Gábor Petővári, Tamás Tölgyes, Kristóf Dede, Attila Bursics, Edit I. Buzás, Zoltán Wiener · 2021 · Research Square
Leveraging technological opportunities in cancer genomics
Jose Espejo Valle-Inclán · 2021
Ovarian Cancer: Towards Personalizing Ovarian Cancer Treatments Using Patient-Derived Organoids
Tatiana Volpari, Jacqueline Hebner, Raeka S. Aiyar, Laura A. Martin · 2021 · Elsevier eBooks
Receptor tyrosine kinase signaling and extracellular matrix cues in ovarian cancer metastasis and drug resistance
Lidia Moyano‐Galceran · 2021 · Figshare
Dormant Cancer Cells: Molecular Features, in vitro Models, and Identification Methods
Sergey V. Nikulin, B. Yа. Alekseev · 2021 · Biotekhnologiya
Using Genetically Encoded Fluorescent Biosensors to Interrogate Ovarian Cancer Metabolism
Shree Bose, Haipei Yao, Qiang Huang, Regina S. Whitaker, Christopher D. Kontos, Rebecca A. Previs, Xiling Shen · 2022 · Research Square
Establishment and Drug Screening of Patient-Derived Extrahepatic Biliary Tract Carcinoma Organoids
Zhiwei Wang, Yinghao Guo, Yun Jin, Xiaoxiao Zhang, Hao Geng, Guangyuan Xie, Dan Ye, Yuanquan Yu, Daren Liu, Donger Zhou et al. · 2021 · Research Square
Tumor heterogeneity in glioblastoma
Maikel Verduin · 2023
A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancer
Alain Valdivia, Adebimpe Adefolaju, Morrent Thang, Luz Andrea Cuaboy, Catherine S. John, Breanna Mann, Andrew Satterlee, Victoria Lin Bae-Jump, Shawn Hingtgen · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Advances in organoid and related biospecimen repository research
Teng HUANG, Lei CHEN, Hongyang Wang · 2024 · Scientia Sinica Vitae
Current and future perspectives of xenograft models of human ovarian cancer
Jun Inoue, Tatsuyuki Chiyoda, Tomoki Muramatsu, Akira Hirasawa, Daisuke Aoki, Johji Inazawa · 2024 · Elsevier eBooks
Application of Cancer Organoids in Pharmacological Research
Masahiro Inoue · 2024 · Drug Delivery System
Organoids research progress in gynecological cancers: a bibliometric analysis
Bing He, Haochuan Ma, Hongbo Yu, Dongmei Li, Li Zhang, Junjie Wang · 2024 · Frontiers in Oncology
The new platform for cancer immunity research: Organoid systems
Ming Tian, Qikun Wang, Tianyin Ma, Chengming Qu, Xiangdong Gongye, Yibo Chai, Shuxian Ma, Yufeng Yuan · 2024 · Elsevier eBooks
A 3D ovarian cancer metastasis model using a decellularized peritoneal matrix to study therapy response
Christiane Helgestad Gjerde, Katrin Kleinmanns, Anika Langer, Gorka Ruiz de Garibay Ponce, Ezekiel R. Rozmus, Gina Nyhus Stangeland, Calum Leitch, Rammah Elnour, Harsh Dongre, Constantin Berger et al. · 2024 · medRxiv
Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response
Lucie Thorel, Énora Dolivet, Pierre‐Marie Morice, Romane Florent, Jordane Divoux, Marion Perréard, Lucie Lecouflet, Guillaume Desmartin, Chloé Marde Alagama, Florence Giffard et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Phenotypic drug discovery
Sonja Sievers, Herbert Waldmann, Slava Ziegler · 2025 · Elsevier eBooks
Pan-Cancer PDOs Preserve Tumor Heterogeneity and Uncover Therapeutic Vulnerabilities
Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza Numan Gokozan, Kathryn Gorski, Pooja Chandra, Jyothi Manohar, Daniela E. Guevara, John R. Otilano, Jenna E. Moyer, Marvel Tranquille et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Advancing clinical outcome predictions via incorporating pharmacokinetic simulations into in vitro testing - a colorectal cancer example
Andrey A. Poloznikov, Ben R. Britt, Sergey V. Nikulin, Sergey Rodin, Karl‐Henrik Grinnemo, Martin Woywod, Jasmin Farouq · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Vision Evaluation of Patient-Derived Organoids for Personalised Medicine
Henrik Vogt, Maxence Gaillard, Sara Green · 2025 · SpringerBriefs in philosophy
Vision Analysis of Patient-Derived Organoids for Personalised Medicine
Henrik Vogt, Maxence Gaillard, Sara Green · 2025 · SpringerBriefs in philosophy
Patient-Derived Organoids: Basic and Translational Research on Uterine Cancer
Yoshiaki Maru, Naotake Tanaka, Yoshitaka Hippo · 2025 · Current human cell research and applications
Nature‐Inspired MYC Inhibitor Disrupts MYC‐Driven Glycolysis and Restricts Ovarian Tumor Growth
Mamta Singh, Anubha Yadav, Umesh Singh, Rajat Gupta, Enrico Cavarzerani, Vincenzo Canzonieri, Deepraj Negi, Akansha Dagar, Bharathwaj Sathyamoorthy, Flavio Rizzolio et al. · 2025 · ChemMedChem
Discovery and targeted mass spectrometry-based proteomics of ovarian cancer
Nicole E. Platzer, Amanda B. Hummon · 2025 · Expert Review of Proteomics
Additional file 2 of Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
Jérôme Cartry, Sabrina Bedja, Alice Boilève, Jacques R.R. Mathieu, Emilie Gontran, Maxime Annereau, Bastien Job, Ali Mouawia, Pierre Mathias, Thierry de Baère et al. · 2024 · Figshare
Additional file 3 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
Additional file 2 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
Additional file 1 of Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
Wang, Zhiwei, Guo, Yinghao, Yun Jin, Zhang, Xiaoxiao, Geng, Hao, Guangyuan Xie, Ye, Dan, Yu, Yuanquan, Liu, Daren, Zhou, Donger et al. · 2021 · Figshare
Additional file 1 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
Additional file 1 of Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien Paula Smabers, G. Emerens Wensink, Carla S. Veríssimo, Esmee Koedoot, Pitsa, Katerina-Chara, Maarten A. Huismans, Celia Higuera Barón, Mayke Doorn, Liselot Valkenburg‐van Iersel, Geert A. Cirkel et al. · 2024 · Figshare
Additional file 2 of Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
Wang, Zhiwei, Yinghao Guo, Yun Jin, Xu Zhang, Geng, Hao, Guangyuan Xie, Ye, Dan, Yu, Yuanquan, Liu, Daren, Zhou, Donger et al. · 2021 · Figshare
Additional file 4 of Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero, Davide Bonvissuto, Francesca Sillano, Marianna Buttarelli, Alessia Piermattei, Matteo Loverro et al. · 2024 · Figshare
Additional file 1 of Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Atthapol Srimongkol, Natanan Laosillapacharoen, Duangporn Saengwimol, Vijender Chaitankar, Duangnate Rojanaporn, Thanastha Thanomchard, Suparerk Borwornpinyo, Suradej Hongeng, Rossukon Kaewkhaw · 2023 · Figshare
Additional file 1 of Assessment of source material for human intestinal organoid culture for research and clinical use
Paulo C. M. Urbano, Hamish C. K. Angus, Safina Gadeock, Michael Schultz, Roslyn A. Kemp · 2022 · Figshare
Development and Application of Tumor Organoids: An Emerging Platform for Gynecological Cancers
Yu Hu, Wei Chen, Xiaojing Zhang, Ying Wu, Furong Du, Jingrui Wang, Meijun He, Wei Tan Sun · 2025 · International Journal of Women s Health
CELLULAR BIOTECHNOLOGIES IN THE MODELING OF CARCINOGENESIS AND THEIR POTENTIAL IN PRECISION MEDICINE
Наханов Азиз Куралбаевич, Sabit Kabdyshevich Kokanov, A. A. Terebay, L. G. Marakhovskaya · 2026 · Biosafety and Biotechnology
MRCKα represses GEF-H1 mediated RhoA activation to promote ovarian cancer spheroid growth and invasion
Aasiya Remtulla, Alison Kurimchak, Alicia Canuel, Ishadi K. M. Kodikara, Jason S. Wasserman, Alexandre Chuyen, Danielle Olding, Rajesh Gupta, Nikolina Radulovich, James S. Duncan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Ascites-Driven Modulation of Cell Phenotypes and Proteomes: Implications for Cancer Progression
Jack Scanlan, Parul Mittal, Jennifer M. Washington, Clifford Young, Martin Klaus Oehler, Peter Hoffmann, Manuela Klingler‐Hoffmann · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Flavonoid GL-V9 as a novel and potent acetyl-coa carboxylase 1 inhibitor confers cisplatin hypersensitivity in ovarian cancer
Zihao Jiang, Yelin Cai, Jie Zhu, Zeyuan Lu, Cong Wang, Baosheng Huang, Qinglong Guo, Hongchuan Zhang, Guo Chen, Yongjian Guo · 2026 · Phytomedicine
Impact of non‐genetic heterogeneity of BRAF ‐mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics
Viktoria Zieger, Ellen Woehr, Jasmin Traichel, Tilman Brummer, Roland Zengerle, Sabrina Kartmann, Stefan Zimmermann · 2026 · International Journal of Cancer
Organoids in Personalised Oncology: Advances and Clinical Translation Toward Precision Cancer Therapy
Shurong Hai, Xishun Zhou, Junbo Li, Xi Zeng, Qi Yu · 2026 · Scandinavian Journal of Immunology
Innovative In Vitro-In Silico Platform for Dose–Response Modeling in Canine Bladder Cancer: A 3D Organoid- and Mathematics-Based Approach
Mackenzie Long, Yvonne Peng, Saumya Gade, Hannah F. Nicholson, Michael Catucci, Christopher Zdyrski, Aleksandra Pawlak, Megan P. Corbett, Corey Saba, Travis Laver et al. · 2026 · The AAPS Journal
Unmasking prostate cancer risk factors leveraging organoid technology
Marta Cantarelli, Elisa Marmocchi, Andrea Lunardi, Rubens Begaj · 2026 · Gene
Engineering in vitro models to target tumour recurrence
Nila C. Wu, Ruonan Cao, Michelle Nurse, Alison P. McGuigan · 2026 · Trends in biotechnology
Development of high throughput approaches to identify cancer-associated long noncoding RNAs
Mohammad Ahmad · 2023
Proposition d'une thérapie photodynamique ciblant FRα pour le traitement des métastases microscopiques des cancers épithéliaux de l'ovaire : Evaluation préclinique de son efficacité anti-tumorale et de ses propriétés adjuvantes immunostimulantes
Léa Boidin · 2024
Développement de nouvelles stratégies thérapeutiques dans les cancers de l’ovaire : intérêt de l’inhibiteur d’HDAC belinostat, seul ou associé avec des molécules BH3-mimétiques, et recherche de stratégies ciblées mimant les mécanismes moléculaires médiateurs de son efficacité
Cécilia Thomine · 2023 · theses.fr (ABES)
Evaluation de deux nouvelles stratégies thérapeutiques ciblant les exosomes tumoraux de Carcinomes du Nasopharynx (CNP) : Proposition d'une stratégie d'Immunothérapie ciblant la galectine-9 et d'une Thérapie Photodynamique au 5-ALA
Camille Trioën · 2024
Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid models
Olivia Craig, Carolina Salazar, Suad M. Abdirahman, Nikita Dalvi, Niveditha Rajadevan, Jennii Luu, Robert Vary, Susanne Ramm, Karla J. Cowley, Ratana Lim et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics
Albert Barrios, Stefani N. Thomas · 2026 · Expert Review of Proteomics
Translational 3D in vitro models for immunotherapy testing: from reconstituted organoid co-culture assays to autologous ex vivo patient tissues
Saskia Madelon Ada de Man, Ezgi Kaya Aksoy, Tomas Veenendaal, Niels Meesters, Sergei Chavez-Abiega, Xuefei Yan, Michelle Kop, Luca Gandini, Jolie Flach, Jiawei Meng et al. · 2026 · Frontiers in Immunology
Single-cell transcriptomics of heterogeneous patient-derived organoids reveals novel therapeutic targets in high-grade serous ovarian cancer
Bisiayo Fashemi, Yukihide Ota, Vijayalaxmi G. Gupta, Maia Lina Elizagaray, Roger Piqué-Regi, Nardhy Gomez‐Lopez, Mary Mullen, Dineo Khabele · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Patient-Derived Organoids Functionally Stratify Epithelial Ovarian Cancer into Clinically Relevant Chemotherapy Response Phenotypes
Shruthi Ragothaman, Raghuveer Reddy, Shelma Cheeran Sajan, Leah Achsah John, Viamaya Biju, Y Vipulachandra, Satish Sankaran, Rohit Raghunath Ranade, Smitha P.K. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)